Devices and Diagnostics

Alcon’s George Shares Passion for Ophthalmology

Alcon’s George Shares Passion for Ophthalmology

By Larry Haimovitch | November 11, 2014

Chicago— Jeff George, Global Head of Alcon Inc., introduced himself to the Ophthalmology Innovation Summit community with a far-ranging keynote address, “Accelerating Innovation in Ophthalmology.”…

Read More
CEOs Share Their ‘Second Acts’ On Way to Building Successful Companies

CEOs Share Their ‘Second Acts’ On Way to Building Successful Companies

By Rich Kirkner | November 11, 2014

Building a successful biotech or biopharma company typically turns on a sentinel event — the pivot, as William J. Link, PhD, Managing Director of Versant…

Read More
FDA Division Directors Detail How Agency Adapts to Innovation

FDA Division Directors Detail How Agency Adapts to Innovation

By Rich Kirkner | November 11, 2014

The rush of innovation in ophthalmology – both in drugs and devices – is driving the Food and Drug Administration to adopt guidelines and standards…

Read More
Avedro Broadens Cross-Link Product Line

Avedro Broadens Cross-Link Product Line

By Tom Salemi | September 9, 2014

Corneal collagen cross-linking has been a vexing specialty for US-based companies trying to guide a product through a cautious FDA. But Massachusetts-based Avedro Inc., continues…

Read More
WaveTec “Must Have” for Alcon

WaveTec “Must Have” for Alcon

By Tom Salemi | September 2, 2014

WaveTec Vision Systems’ CEO, Tom Frinzi, delivered a bottom-line presentation at the Ophthalmology Innovation Summit @ASCRS in Boston. His six-minute presentation concentrated on the economic…

Read More
2014 OIS@ASCRS Executive Report

2014 OIS@ASCRS Executive Report

By Larry Haimovitch | July 15, 2014

BOSTON — The Third Annual Ophthalmology Innovation Summit (OIS@ASCRS) took place on April 24, just prior to the 2014 annual meeting of the American Society…

Read More
“The Long and Winding Road”

“The Long and Winding Road”

By Larry Haimovitch | April 16, 2014

The March 14th meeting of the FDA’s Ophthalmic Devices Panel Advisory Committee, which was convened by the FDA to consider the pre-market application (PMA) for…

Read More
2013 OIS@AAO Executive Summary – Eye on Innovation

2013 OIS@AAO Executive Summary – Eye on Innovation

By Tom Salemi | December 19, 2013

More than 800 attendees participated in the fifth annual Ophthalmology Innovation Summit, held November 14, 2013, just prior to the annual meeting of the American…

Read More
Funding Ophthalmology Innovation: The Focus of Science and Capital

Funding Ophthalmology Innovation: The Focus of Science and Capital

By Tom Salemi | September 23, 2013

Ophthalmology is a growing, but challenging, market. Innovation is abounding in its research stages and some people in the know foresee more positive development in…

Read More
FDA Focus on More Efficient Processing Yields Faster Decisions

FDA Focus on More Efficient Processing Yields Faster Decisions

By Tom Salemi | June 25, 2013

SAN FRANCISCO — The U.S. Food and Drug Administration has been criticized for its ponderous movement of potential drugs and medical devices through the approval…

Read More
All Eyes on Ophthalmic Innovation: An Interview with Bill Link

All Eyes on Ophthalmic Innovation: An Interview with Bill Link

By Tom Salemi | April 20, 2013

The ophthalmology drug, device and medical technology sector is poised for continued growth, as innovators and entrepreneurs unblinkingly stare down the ongoing domino effect being…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.